Payments to Acquire Property, Plant, and Equipment of KalVista Pharmaceuticals, Inc. from 31 Dec 2013 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
KalVista Pharmaceuticals, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2013 to 31 Jul 2025.
  • KalVista Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Jul 2025 was $290,000, a 1281% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $434,000, a 933% increase from 2023.
  • KalVista Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $42,000, a 96% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1,196,000, a 28% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

KalVista Pharmaceuticals, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $290,000 +$269,000 +1281% 01 May 2025 31 Jul 2025 10-Q 11 Sep 2025 2026 Q1
Q2 2024 $21,000 +$15,000 +250% 01 May 2024 31 Jul 2024 10-Q 11 Sep 2025 2026 Q1
Q2 2023 $6,000 -$914,000 -99% 01 May 2023 31 Jul 2023 10-Q 05 Sep 2024 2025 Q1
Q2 2022 $920,000 +$633,000 +221% 01 May 2022 31 Jul 2022 10-Q 07 Sep 2023 2024 Q1
Q2 2021 $287,000 +$265,000 +1205% 01 May 2021 31 Jul 2021 10-Q 08 Sep 2022 2023 Q1
Q2 2020 $22,000 -$76,000 -78% 01 May 2020 31 Jul 2020 10-Q 09 Sep 2021 2022 Q1
Q2 2019 $98,000 -$467,000 -83% 01 May 2019 31 Jul 2019 10-Q 14 Sep 2020 2021 Q1
Q2 2018 $565,000 +$455,000 +414% 01 May 2018 31 Jul 2018 10-Q 09 Sep 2019 2020 Q1
Q2 2017 $110,000 +$67,000 +156% 01 May 2017 31 Jul 2017 10-Q 14 Sep 2018 2019 Q1
Q2 2016 $43,000 01 May 2016 31 Jul 2016 10-Q 14 Sep 2017 2018 Q1
Q1 2016 $184,000 +$4,000 +2.2% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2016 2016 Q1
Q1 2015 $180,000 +$179,000 +17900% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $1,000 01 Jan 2014 31 Mar 2014 10-Q 21 May 2015 2015 Q1

KalVista Pharmaceuticals, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $434,000 +$392,000 +933% 01 May 2024 30 Apr 2025 10-K 10 Jul 2025 2025 FY
2023 $42,000 -$1,154,000 -96% 01 May 2023 30 Apr 2024 10-K 10 Jul 2025 2025 FY
2022 $1,196,000 +$265,000 +28% 01 May 2022 30 Apr 2023 10-K 11 Jul 2024 2024 FY
2021 $931,000 +$849,000 +1035% 01 May 2021 30 Apr 2022 10-K 11 Jul 2024 2024 FY
2020 $82,000 -$138,000 -63% 01 May 2020 30 Apr 2021 10-K 10 Jul 2023 2023 FY
2019 $220,000 -$861,000 -80% 01 May 2019 30 Apr 2020 10-K 07 Jul 2022 2022 FY
2018 $1,081,000 -$346,000 -24% 01 May 2018 30 Apr 2019 10-K 13 Jul 2021 2021 FY
2017 $1,427,000 +$1,353,000 +1828% 01 May 2017 30 Apr 2018 10-K 01 Jul 2020 2020 FY
2016 $74,000 -$585,000 -89% 01 May 2016 30 Apr 2017 10-K 16 Jul 2019 2019 FY
2015 $659,000 +$500,000 +314% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
2014 $159,000 +$141,000 +783% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $18,000 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.